Outsourcing Pharma
-
Lucky Seven For Winning CDMOs — And Their Sponsors
3/7/2018
Outsourced Pharma Chief Editor Louis Garguilo talks about what makes this seventh edition of the Life Science Leader CMO Leadership Awards different from the previous years.
-
Outsourcing Relationships Benefit From Aligning CMO Expertise With Sponsor Needs
3/7/2018
This year’s CMO Leadership Awards result from feedback obtained through four different contract manufacturing surveys — biologic API, biologic drug product, small molecule API, and small molecule drug product — conducted by Industry Standard Research.
-
During A Tech Transfer, There Is No Substitute For Boots On The Ground
3/7/2018
Ray Sison, VP of pharmaceutical outsourcing and tech transfer at xCell Strategic Consulting, recounts how one of his tech transfers went bad and the five important points he learned as a result of the experience.
-
Is Your CDMO Listening To Your Small-Company Needs?
3/7/2018
Small companies can often encounter situations in which contract organizations devote their best people to their larger sponsors. Therefore, to ensure you get the attention your small-company project deserves, you need to take some proactive steps.
-
How Some Sponsors Internally Evaluate Their CDMOs
3/7/2018
A panel of supply chain experts share best practices and perspectives on what parameters to use in evaluating CMOs/CDMOs, how to address low performance partners, and how to meet growing FDA expectations.
-
When Is Virtual The Right Course Of Action?
3/7/2018
A look at three scenarios that may impact the decision of virtual or in-house manufacturing, as well as key aspects to consider in the selection process and in forming a strong relationship between the company and CDMO.
-
What Does Data Integrity Mean To Sourcing Professionals?
3/5/2018
Sourcing professionals spend a great deal of time identifying and vetting suppliers. There are steps you can take early in the process to limit the likelihood of choosing a supplier with a major quality issue, specifically risks associated with data integrity.
-
3 Compelling Reasons To Form Strategic Partnerships With CDMOs
2/27/2018
The past decades have seen a maturation of the contract development and manufacturing organization (CDMO) business and an increased level of collaboration between pharma companies and CDMOs.
-
Virtual And Variable: Two Visions For Biopharma Outsourcing In 2018
12/7/2017
Deborah Dunsire, CEO of XTuit Pharmaceuticals; and Robert Discordia, executive director, global product development & supply procurement for Bristol-Myers Squibb discuss new approaches to external partnerships in pharma.
-
How Amazon Could Disrupt The CRO Model
10/24/2017
Based on Amazon's approach to building its business, it is logical to conclude that the online retailer would be an amazing CRO. Amazon’s competitive strategy is to aggressively discount prices to win market share. Plus, its customer obsession and disruptive innovation are second to none. Let’s imagine what an Amazon-run CRO would look like.